Fundraising Fox
Digitalis Ventures
Venture capitalNew York · Seed–Series A · 15 people tracked
Also known as Digitalis · DIGITALIS VENTURES, LLC
Find your way into Digitalis Ventures
Sign up to see every warm intro you have to Digitalis Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Digitalis Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Digitalis Ventures focuses on solutions to unmet needs in biomedicine and health. On the human health side, it backs biotechnology companies leveraging breakthrough science, as well as companies building novel technology-enabled solutions that improve access to care and health outcomes while lowering costs for individuals and the broader healthcare system. Through its Companion Funds, the firm also invests in companies applying science, technology, and design to improve animal health. Digitalis emphasizes a multidisciplinary team approach to solving complex problems and shares its investment thinking publicly through the Digitalis Notebook, alongside its related efforts at Digitalis Commons and Digitalis Labs.
Source: firm website, verified Sep 29, 2026.
Team · 15 people
from the firm's website & public directories
Founder mafia
5 people who came through Digitalis Ventures went on to found or lead other companies.
What they invest in
from 58 of 75 portfolio companiesBiotech ×38Healthtech ×33Deep Tech ×13AI & Machine Learning ×12Medical Devices ×12Digital Health ×11Consumer ×6Fintech ×6
HQs:United States×45Australia×1Canada×1Colombia×1Germany×1France×1
Who they back
founder profiles across 10 portfolio companiesFounding team size:solo founder×52 founders×13 founders×34+ founders×1
Where their founders studiedfrom 11 founders with education data
Caltech ×2Princeton University ×2
What their founders studiedfrom 10 founders with field-of-study data
Chemistry ×2Engineering ×2Life Sciences ×2Physics ×2Politics & Policy ×2
Where their founders worked beforefrom 12 founders with career history
Atlas Venture ×2Wyss Institute for Biologically Inspired Engineering ×2
Investments · 75 tracked
founders shown can be your intro pathBy year:2026 · 62025 · 52024 · 82023 · 42022 · 42021 · 62020 · 12019 · 52018 · 32017 · 52016 · 12015 · 149 dated
Faeth Therapeutics is a clinical-stage oncology company developing therapies that inhibit multiple nodes of the PI3K/AKT/mTOR (PAM) pathway.
BiotechHealthtechAustin, US
Anand Parikh(Executive Officer, Director, Promoter)inOliver Maddocks(Executive Officer, Director)inChristopher W. Gerry(President and General Counsel)
BoardAlex Morgan(Director)inJayson Dallas(Director)Robert Gould(Director)
Co-investorsAble PartnersAtacama VenturesCota CapitalFuture VenturesiSelect FundS2G Investments+7 more
Judo Bio develops oligonucleotide medicines, including ligand-siRNA conjugate drugs, delivered to the kidney for systemic and renal diseases using its STRIKE (Selectively Targeting RNA Into KidnEy) platform.
BiotechHealthtechCambridge, US
Andrew Fraley(Judo Bio Co-Founder)inAlfica SehgalinOMMER CHOHAN(Executive Officer)inJAMES JEFFREY GOATER(Executive Officer, Director)Simon Read(Executive Chair and Acting CEO)inWilliam Ho
Co-investorsAtlas VentureDroia VenturesThe Column GroupYK Bioventures
Gallant develops regenerative medicine therapies for veterinary care, bringing treatments from laboratory research into clinical practice for pets.
BiotechHealthtechMedical DevicesSan Diego, US
Aaron Hirschhorn(Founder)Linda Black(Chief Executive Officer; founding team member)inDavis Brimer(Executive Officer, Director)Beau Becker(Head of Strategic Operations & People Effectiveness; founding team member)in
BoardTeymour Boutros-Ghali(Director)inValentine Williams(DVM, MS, Diplomate ACVS)
Board seatMisti Ushio· per SEC Form D
Co-investorsAlpha EdisonAlumni VenturesBaroda VenturesBling CapitalBold Capital PartnersExpansion Venture Capital+3 more
The page announces the launch of a new fintech arm called CapForce.
BiotechFintechGaithersburg, US
Evan Jones(Executive Officer, Director)Vadim Sapiro(Executive Officer)inC. Eric Winzer(Executive Officer)David Hoekzema(Executive Officer)inTerry Walker(Executive Officer)C. Douglas White(Executive Officer, Director)
Board seatMisti Ushio· per SEC Form D · $1.5M raise · filed Jun 2017
Co-investorsCross Creek AdvisorsIn-Q-TelHighland Capital Partners
CE Brands, Inc. designs, manufactures, and distributes smart consumer electronic products, including connected health wearables and health analytics software, in partnership with manufacturers, brands, and retailers.
ConsumerHardwareHealthtechIoTNew York, US
Eran Ofir(Executive Officer, Director)inCharles Herman(Executive Officer, Director)in
BoardMeir Akkerman(Director)Andrew Gianonne(Director)Christopher Geczy(Director)
Board seatDrew TaylorAmit Bansal· per SEC Form D
Co-investorsEast Post Road VenturesKleiner Perkins
Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development.
BiotechDigital HealthMedical DevicesVancouver, CA
François Bénard(Founder)Kuo-Shyan Lin(Founder)David Perrin(Founder)
Co-investorsAndreessen HorowitzAscenta CapitalDelos CapitalFrazier Life SciencesGeneral CatalystLightspeed Venture Partners+9 more
.png)
Alterome is a clinical-stage precision oncology company developing small-molecule, alteration-specific cancer therapies, with two internally discovered drug candidates in the clinic.
AI & Machine LearningBiotechDeep TechSan Diego, US
Eric A. Murphy(Executive Officer, Director, Promoter)inRyan B. Corcoran(Director, Promoter)Richard Heyman(Founder)
BoardThilo Schroeder(Director)inCarl Gordon(Director)inArjun Goyal(Director)in
Co-investorsCanaan PartnersNextech InvestOrbiMedVida VenturesNVIDIA
Ansel Health provides health benefit solutions focused on cost-sharing and coverage for unexpected medical bills for employer groups and individuals.
ConsumerHealthtechInsurTechHoboken, US
Veer GidwaneyinAmanda Turcotte(Executive Officer)in
BoardColin Beire(Director)Elizabeth Bierbower(Director)
Co-investors500 GlobalAlumni VenturesCity LightFounder CollectiveBrewer Lane VenturesGovtech Fund+2 more
Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages.
BiotechHealthtechMedical DevicesMunich, DE
Evis Hursever(Executive Officer)Wesley McConnell(Executive Officer)inMichael Stella(Executive Officer, Director)William Hawkins(Executive Officer)
BoardMichael Beecham(Director)Andrew Kozlov(Director)
Co-investorsCathay HealthDCVC (Data Collective)Monograph Capital Partners4BIO Capital
Biotechnology company developing immunomodulators using a HALOS nanotechnology platform for chronic inflammation.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Michael Tolentino(Executive Officer, Director)inMohamed A. Genead(Chairman & CEO)inDavid Callanan(Executive Officer)inDerek Kunimoto(Executive Officer)inJeffrey Nau(Chief Executive Officer)inTarek S. Hassan(Chief Development Officer)in
Co-investorsJeito CapitalLongitude CapitalCatalio Capital Management, LPOrbiMedAvoro Capital AdvisorsOmega Funds
B5 Genomics offers the Benthic Analysis Platform, software that converts microarray and sequencing data (short-read and long-read) into high-resolution genotyping and variant calls for complex genomic regions such as HLA, KIR, and the MHC.
AI & Machine LearningBiotechHealthtech
Bonum Therapeutics develops antibody-controlled protein therapeutics that remain inactive until bound to their target, using a sensor-domain mechanism to deliver regulated, targeted activity.
BiotechHealthtechSeattle, US
John Mulligan(Executive Officer, Director, Promoter)inNeela Patel(Executive Officer)inDiane Hollenbaugh(Executive Officer)in
BoardSamuel Bjork(Director)inMonique Schiersing(Director)inJohn McKearn(Director)in
Co-investorsRiverVest Venture PartnersRoche Venture FundVivo Capital3x5 PartnersCodon Capital
Buddy provides a digital commerce platform for insurance that converts product rules, pricing, and workflows into structured data and deploys them as modern buying experiences across multiple channels.
AI & Machine LearningFintechInsurTechSaaS
Charles Merritt(Co-Founder, CEO)inDavid Vogeleer(Co-Founder, CTO)in
Co-investorsAbstraction CapitalNewlin Ventures
Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment.
ConsumerDigital HealthHealthtechMedical Devices
Nick Greenfield(Founder)in
Co-investorsA-Rod CorpAverin CapitalBessemer Venture PartnersBeyond CapitalF-Prime CapitalFantail Ventures+9 more
Cardurion is a cardiovascular disease-focused company developing therapeutics, with a pipeline advanced through clinical development, trial design, regulatory affairs, and commercialization.
BiotechDigital HealthHealthtechMedical DevicesBurlington, US
Michael E. Mendelsohn(Founder and Chief Strategy Officer)in
Co-investorsBain CapitalAscenta CapitalDelos CapitalNew Enterprise Associates (NEA)Bain Capital Life SciencesBain Capital Tech Opportunities+4 more
CareDox (operating as SchoolCare) provides a digital health record platform for K-12 school nurse offices that manages immunizations, chronic disease information, and student health compliance reporting.
Digital HealthEdTechHealthtechForest Hills, US
Hesky Kutscher(Executive Officer, Director)in
BoardGreg Goff(Director)Eyal Niv(Director)
Co-investorsKima Ventures7wire VenturesFirst Round CapitalProlog VenturesStartUp HealthTEXO Ventures+1 more
Clasp connects employers with healthcare students before graduation and ties student loan repayment to employment, addressing both clinical workforce shortages and student debt.
EdTechFintechHealthtechHR TechBoston, US
Tess Michaels(Founder)in
Co-investorsCrosslink CapitalGSV VenturesJuvo VenturesBase10 PartnersBlumberg CapitalGradient Ventures+1 more
Clasp provides API-based infrastructure and automation for employee health benefits administration, handling quoting, group setup, open enrollment, carrier feeds, and ACA/COBRA compliance.
FintechInsurTechSaaS
Co-investorsConversion CapitalTerrainCrosslink Capital
Code Ocean is a cloud computational research platform for reproducible code, data and environments in science.
New York, US
Simon Adar(Founder)in
BoardScott Tobin(Director)inJoshua Ruch(Director)inMarty Kahn(Director)
Co-investorsBattery VenturesBeaconsfield CapitalKreos CapitalM12 (Microsoft's Venture Fund)Olima VenturesUpmost Capital Limited+1 more
Eden Brew develops food and supplementation products designed to deliver nutrition in natural forms that align with how the human body processes nutrients, with a focus on sustainable scaling and long-term health support.
BiotechDeep TechFoodTechHealthtechImpact & Social Good
Co-investorsBreakthrough VictoriaMain Sequence VenturesPossible VenturesRadar Ventures
Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.
BiotechDeep TechSan Carlos, US
Matthew Hill(Executive Officer, Director)in
BoardPeter Zhou(Director)inCain McClary(Director)inJonathan Sheena(Director)in
Co-investorsACVC PartnersAndreessen HorowitzIn-Q-TelRaptor GroupTriatomic CapitalAME Cloud Ventures+1 more
Elemental Machines provides an IoT platform combining hardware, software, and data science to monitor lab and manufacturing equipment, environments, and workflows in real time.
AI & Machine LearningBiotechHardwareHealthtechIoTSaaSCambridge, US
Sridhar Iyengar(Executive Officer, Director)inUna Ryan(Director)Jeff Klemens(Director)inSonny Vu(Director)in
BoardGaurav Tewari(Director)inRobert Davoli(Director)in
Co-investorsGutbrain VenturesHemisphere Ventures LLCJoint EffectsOmega Venture PartnersSageview CapitalTau Ventures+2 more
Sridhar Iyengar(Founder)
Co-investorsHealthtech CapitalGutbrain VenturesKdT Ventures
Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.
BiotechMedical DevicesSan Mateo, US
Ann Lee-Karlon(Executive Officer, Director)inMitchell Mutz(Executive Officer, Director)James Wells(Director)
BoardSamuel Bjork(Director)inAlexandra Cantley(Director)inSeiji Miyahara(Director)in
Co-investorsAvego BioScience CapitalGV (Google Ventures)Mission BiocapitalNovartis Venture FundRoche Venture FundSamsara BioCapital+4 more
Expressable provides speech therapy services using research-based techniques with a focus on family engagement and accessibility.
Digital HealthHealthtechSaaSAustin, US
Nicholas Barbara(Executive Officer, Director)inLeanne Sherred(President and Chief Clinical Officer)inBenjamin Pincus(Executive Officer)inSpencer Magloff(Executive Officer)inRyan Hinojosa(Executive Officer)
Co-investorsF-Prime CapitalLerer HippeauNextView VenturesHarbourVest Partners (Canada)
Co-investorsNoro-Moseley PartnersSustainVC
Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.
HealthtechMiami Lakes, US
Carlos D. Bustamante(Executive Officer, Director)inArthur Polk(Executive Officer)Alexander Ioannidis(Director)
BoardWale Ayeni(Director)inMohit Kaushal(Director)Nicholas Katsanis(Director)
Co-investorsCEI VenturesCitta CapitalF-Prime CapitalFounder CollectiveFunction VenturesHelios Digital Ventures+4 more
Portfolio company acquired by Roche.
BiotechSeattle, US
John Mulligan(Executive Officer, Director, Promoter)inMitchell Mutz(Director)Nicholas Walrod(Director)
BoardJohn McKearn(Director)inKarl Handelsman(Director)
Co-investorsRiverVest Venture Partners3x5 PartnersCodon CapitalRoche Venture Fund
GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function.
BiotechDeep TechHealthtechCambridge, US
Daniel J Mandell(Chief Executive Officer)Tracey Lodie(Executive Officer)inChristopher Gregg(Director)
BoardMing Fang(Director)Bruce Beutel(Director)Dan Becker(Director)
Co-investorsLeaps by BayerREDMILEAlumni VenturesDreamers VCRising TideAccess Industries+3 more
Helm Health provides benefit design and member engagement tools for health plans, incorporating cost and quality data into coverage decisions, bundling claims into transparent pricing, and offering provider search functionality.
Enterprise SoftwareHealthtechInsurTechSan Francisco, US
Co-investors.406 Ventures3CC | Third Culture CapitalFlare Capital PartnersHeadwater VenturesSemperVirens Venture CapitalInitialized Capital
Kenzen develops AI-powered occupational health and safety systems that integrate predictive analytics and real-time monitoring to reduce workplace injuries and improve workforce performance.
AI & Machine LearningEnterprise SoftwareHealthtechHR TechSan Francisco, US
Sonia Sousa(Executive Officer, Director)
BoardJake Ireland(Director)Lorenzo Thione(Director)Steven Pecko(Director)
Co-investorsEmpire AngelsEvolution VC PartnersKCRise FundRoyal Street Ventures Management Company, LlcSand Hill AngelsWorking Capital Fund+2 more
Kingdom Superculture develops functional health ingredients derived from natural microbes, targeting consumers seeking effective nutritional and health products.
BiotechConsumerFoodTechHealthtechNew MaterialsWellness & FitnessNew York City, US
Kendall Dabaghi(Founder)inRavi Sheth(Founder)inTom Blazejewski(Senior Machine Learning Scientist)Austin Kane(Bizops Associate)Peter Stein(Senior Data Engineer)
Co-investors4DX VenturesFour Acres CapitalPioneerShine CapitalSupernode VenturesValor Equity Partners+25 more
Discovering precision small molecule medicines that harness the power of covalency to transform the treatment of immune diseases.
BiotechCambridge, US
Andre Turenne(Executive Officer, Director)in
BoardJason Hafler(Director)inBruce Booth(Director)Daniel Becker(Director)
Co-investorsAccess BiotechnologySanofi VenturesAccess IndustriesAlexandriaAtlas Venture
Matchpoint Therapeutics is a drug discovery company developing precision small molecule covalent medicines to treat immune and inflammatory diseases.
AI & Machine LearningBiotechDeep Tech
Andre TurenneJared Cumming(PhD)Christopher HrenThomas Durand-Reville(PhD)Wei Li(MD)Paola Castaldi(PhD)
Co-investorsAtlas VentureSanofi Ventures
Subscription e-commerce platform for pet owners in China.
Co-investorsCompanion FundDCM VenturesDCMFJ LabsSeek VenturesTekton Ventures+1 more
Centennial, US
Dennis J. Chmiel(Executive Officer, Director)Jen Hagness(Executive Officer, Director)inNancy A. Willerton(Executive Officer, Director)Dennis J. Chmiel Jr.(Executive Officer, Director)
BoardCindy Cole(Director)Jeremy L. Friese(Director)
Native Pet makes veterinarian-developed nutritional supplements for dogs, including chews, powders, and bone broths that target digestion, joints, skin and coat, calming, and bladder health.
ConsumerDirect to ConsumerWellness & FitnessSt Louis, US
Patrick M Barron(Manager / Member)
Co-investorsCompanion FundR/GA VenturesSelva VenturesCAVU Consumer Partners
Neion Bio operates a biomanufacturing platform that re-engineers eggs into living bioreactors using genetic engineering and stem cell biology to produce biological molecules such as monoclonal antibodies, enzymes, fusion proteins, peptides, and cytokines.
Advanced ManufacturingBiotechDeep TechNew York, US
Sam Levin(Founder)inDimi Kellari(Founder)in
Co-investorsCaffeinated CapitalClocktower VenturesHAWKTAILBasis Set VenturesEnsemble VCHaystack+1 more
Nuvig Therapeutics develops immune-modulating medicines for autoimmune diseases by harnessing endogenous regulatory mechanisms to resolve immune dysregulation.
BiotechHealthtechMedical Devices
Pamela Conley(Founder)in
Co-investorsB Capital GroupB4 CapitalGlobal BioAccess FundMission BiocapitalSanofi VenturesNorwest Venture Partners
.jpeg){kind=logo}
Nuvig Therapeutics is a biotech company developing immune-modulating therapies for autoimmune and chronic inflammatory diseases, using an endogenous regulatory mechanism intended to treat inflammation without compromising broader immune function.
BiotechLongevity
Co-investorsSanofi Venturesabrdn plcAlexandriaB CapitalGlobal BioAccess FundLeaps by Bayer+4 more
Omni makes electric scooter attachments that connect to wheelchairs, letting wheelchair users travel on urban and off-road terrain; the company states 95% of wheelchairs are compatible with its devices.
HardwareHealthtechMobility & Transportation
Co-investors50 PartnersCraft VenturesFirst Round CapitalGV (Google Ventures)ICONIQICONIQ Growth+6 more
Omni is a non-custodial multi-chain crypto wallet that lets users store, bridge, and swap tokens across multiple blockchains, import wallets from MetaMask, Keplr, and Phantom, build custom portfolios, and buy crypto with a credit card.
Crypto & Web3Fintech
Serafin Lion Engel(Founder)
Co-investorsFigmentFlori VenturesCraft VenturesEmerge VenturesFirst Round CapitalGV (Google Ventures)+11 more
Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making.
AI & Machine LearningBiotechDigital HealthSan Carlos, US
Akshay Nanduri(Founder)inSalmaan Ahmed(Executive Officer)Jonathan Fleming(Director)
Co-investors515 VenturesLifeX VenturesBlue Venture FundsKdT Ventures
Novel antibody-based therapeutics platform for animal health.
Co-investorsCambridge Innovation CapitalCompanion FundParkwalk AdvisorsVCapital
Positive Development provides autism therapy and developmental care services for neurodivergent children and their families.
Digital HealthHealthtechMedical DevicesMental HealthMclean, US
Mike Suiters(Executive Officer, Director)inNick Whitehead(Director)in
BoardAdam Seabrook(Director)inDaniel Gebremedhin(Director)John Banta(Director)inBrenton Fargnoli(Director)in
Co-investorsAlleyCorpaMoonB Capital GroupB4 CapitalFlare Capital PartnersLifeforce Capital+3 more
Protego provides chargeback management software that automates dispute processes and tracks chargebacks in real time to help merchants identify patterns in fraudulent activity and recover revenue.
CybersecurityEnterprise SoftwareSaaSBogotá, CO
Pablo Rojas(Founder)inRafael Casabianca
Co-investorsNovartis Venture FundY CombinatorDroia VenturesForbionGlilot Capital PartnersGlobal Founders Capital+7 more
Protego Bio is a biotech company developing first-in-class therapies for protein misfolding diseases, including its lead candidate PROT-001 for AL amyloidosis, based on research into pharmacological chaperones.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Diego, US
Brent J. Warner(Executive Officer, Director)inXIN JIANG(President & CEO)inHANK MICHAEL PETRASSI(Executive Officer)JEFFERY KELLY(Director)
BoardTIM LOHOFF(Director)Edward Hurwitz(Director)
Co-investorsDroia VenturesNovartis Venture FundForbionLightspeed Venture PartnersMPM BioImpactVida Ventures+1 more
Reema Health provides a personalized, community-based care model that connects people to health care and social support services in their local communities.
Digital HealthHealthtechImpact & Social GoodMental HealthMinneapolis, US
Justin Ley(CEO)inMatt(Chief Product Officer)
BoardHelen Ciesielski(Director)inMatthew Swanson(Director)Ellen Herlacher(Director)inAmon Anderson(Director)
Co-investorsGROOVE CAPITALHC9 VenturesHeadwater VenturesLRVHealthMaC Venture CapitalMatchstick Ventures+3 more
.png)
Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.
BiotechHealthtechLongevitySan Diego, US
Noah Davidsohn(CSO, Co-Founder)inDaniel Oliver(CEO, Co-Founder)inGeorge Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)in
Co-investorsCompanion FundConnecticut InnovationsKendall Capital PartnersLifespan Vision VenturesVCapitalKdT Ventures
SchoolCare provides a healthcare platform focused on improving health services for children, serving schools, parents, and payers.
Digital HealthEdTechHealthtechSaaSNew York, US
Co-investors7wire VenturesCorewell Health VenturesCherre
Scout Bio developed biotechnology therapies for pets, including a pipeline of monoclonal antibodies and gene therapy programs targeting chronic diseases in companion animals.
AgTechBiotechDeep TechHealthtechPhiladelphia, US
Mark Hefferman(Executive Officer, Director)
BoardAditya Kohli(Director)inTadataka Yamada(Director)Patrick Heron(Director)inCindy Cole(Director)inNancy Hong(Director)
Co-investorsCompanion FundCorrelation VenturesFrazier Life SciencesRiverVest Venture Partners
Scratch Pay offers point-of-payment patient financing that lets clients of veterinary practices apply for loans and receive instant decisions, with practices paid up front via ACH.
ConsumerFintechHealthtechLos Angeles, US
Caleb(Founder/President)John Keatley(Founder)inCaleb Morse(Founder)
Co-investorsArgonautic VenturesCompanion FundFJ LabsNorwest Venture PartnersStruck CapitalSWS Venture Capital+1 more
BiotechWaltham, US
Ellen E. Sheets(Executive Officer, Director)in
BoardCarl M. Berke(Director)inNancy Hong(Director)in
Co-investorsBold Capital PartnersRiverVest Venture PartnersKdT Ventures
Smalls produces fresh, gently cooked cat food made to resemble home-prepared meals, differentiating itself from conventional pet food manufacturers by using minimal processing.
Direct to ConsumerFoodTech
Matthew Michaelson(Founder)inCalvin Bohn(Founder)Matt Michaelson(Founder)
Co-investorsCompanion FundEastward Capital PartnersEvolution VC PartnersFounder CollectiveGeneral MillsImaginary Venture Capital+8 more
Switch Therapeutics develops RNA interference (RNAi) therapeutic applications targeting central nervous system diseases, leveraging research from Caltech, Harvard Medical School, and City of Hope.
AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US
Si-Ping Han(Secretary)inDeepshikha Datta(Chief Executive Officer and President)
BoardKevin Zhang(Director)Alicia Irurzun-Lafitte(Director)inDylan Morris(Director)in
Co-investorsBold Capital PartnersCRV (Charles River Ventures)Dolby Family VenturesFREEFLOWGlobal BrainOno Venture Investment, Inc.+3 more
T-Therapeutics develops T cell receptor-based therapeutics for cancer and autoimmune diseases using its proprietary OpTiMus platform, which identifies antigen-specific human TCRs.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, GB
Co-investorsCambridge Innovation CapitalF-Prime CapitalSanofi VenturesSofinnova PartnersBusiness Growth FundUniversity of Cambridge Enterprise
Tenvie is a clinical-stage biopharmaceutical company developing small molecule and biologic therapeutics for neurological and peripheral diseases.
BiotechMedical Devices
Tony Estrada(President & Chief Executive Officer)in
Co-investorsARCH Venture PartnersF-Prime CapitalBain Capital Life SciencesForbionMubadala Capital
Terray is a drug discovery company that combines proprietary hardware, large-scale experimental datasets, and AI through its EMMI platform to design small molecule medicines.
AI & Machine LearningBiotechDeep TechPasadena, US
Eli Berlin(Founder)inJacob Berlin, Ph.D.(Chief Executive Officer)Jacob Berlin(Founder)Jacob Berlin Eli Berlin(Founder)Nathan Collins(Founder)
BoardChris Picardoin
Co-investorsDeviation CapitalMadrona Venture GroupSummit Peak InvestmentsAlexandriaKdT VenturesMana Ventures+5 more
Transcera is a biotech company developing a new class of therapeutics that use lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, aimed at treating chronic diseases.
BiotechDeep TechBoston, US
Wayne Lencer(Founder)Hunter Goble(Founder)inJustin Wolfe(Founder)inWilliam Hunter Goble(Executive Officer, Director)Phil Grayeski(Director)
Co-investorsPear VCPortal InnovationsTau VenturesKdT VenturesTAU VenturesXora Innovation Pte Ltd
Travv develops AI-powered veterinary diagnostics, including digital pathology tools for the animal health industry.
AI & Machine LearningBiotechCloud ComputingHealthtech
Derick Whitley(Founder, CEO)in
Co-investorsCompanion Fund
Varda industrializes low Earth orbit by manufacturing pharmaceuticals and other specialized products in space, then returning them to Earth via reusable reentry capsules.
BiotechDeep TechSpace TechEl Segundo, US
Will Bruey(Founder)inDelian Asparouhov(Founder)inDaniel Marshall(Founder)Trae Stephens(Director)Josh Wolfe(Director)
Co-investorsAlso CapitalCaffeinated CapitalFounders FundGeneral CatalystKhosla VenturesLux Capital+36 more
_imresizer.png)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Lodo TherapeuticsSenova SystemsAlcea TherapeuticsAnselAscendAunt BerthaCardurion PharmaceuticalsDecoGirihletHelm HealthNapo Pet InsuranceSecond GenomeTerray
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 4
1 IPOs · 3 acquisitions · showing 3Faeth TherapeuticsNASDAQ: FTHGood Therapeuticsacq. by RocheScout Bio Incacq. by Ceva Santé Animale
Portfolio news
latest coverage across their companies
Rejuvenate Bio · finsmes.com · Jun 8, 2026
Travv · finsmes.com · May 7, 2026
Neion Bio · finsmes.com · Mar 27, 2026
Elemental Machines · trysignalbase.com · Mar 25, 2026
Reema · biospace.com · Dec 3, 2025
Positive Development · finsmes.com · Aug 6, 2025
Bonum Therapeutics · biospace.com · Jun 10, 2025
Frequently asked questions
- How many investments has Digitalis Ventures made?
- Digitalis Ventures has 75 tracked investments, 4 of which have exited, including 14 dated in the last 24 months.
- What stage does Digitalis Ventures invest at?
- Digitalis Ventures invests at the Seed, Series A stages.
- What is Digitalis Ventures's typical check size?
- Digitalis Ventures typically writes checks of $100K – $10M.
- What sectors does Digitalis Ventures focus on?
- Digitalis Ventures focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Digitalis Ventures located?
- Digitalis Ventures is headquartered in New York, US.
- Does Digitalis Ventures lead rounds?
- Yes, Digitalis Ventures leads investment rounds.
- Who does Digitalis Ventures co-invest with?
- Digitalis Ventures most often shares deals with Companion Fund, RiverVest Venture Partners, VCapital, among 51 tracked co-investors.
Images
Co-investors · 29
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
Roche Venture Fund is a corporate venture arm that invests in early-stage biotech and diagnostics companies across more than 10 countries, with a portfolio exceeding 30 portfolio companies. The fund is headquartered in Basel, Switzerland.
RiverVest Venture Partners is a life sciences venture capital firm that invests in biotechnology and medical companies, working with entrepreneurs to advance therapeutic and medical innovations.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Founder Collective is a seed and pre-seed stage venture capital firm that invests across sectors, describing itself as sector agnostic and anti-thematic.
BOLD Capital Partners is a venture capital firm that backs entrepreneurs and companies pursuing transformative science and technology aimed at disrupting and democratizing large markets and addressing major human challenges.
Two Sigma Ventures has rebranded and is now known as Deviation Capital; the page directs visitors to the new website.
GutBrain Ventures is an early-stage technology venture capital firm led by investor and former entrepreneur Bob Davoli, who partners closely with founders and management teams to help build and scale high-growth software and technology companies.
MPM BioImpact combines 30+ years of biotech venture capital expertise with impact investing and public market experience, managing early-stage venture funds, private/public impact funds, and a public equities fund focused on transforming patient outcomes.
Cambridge Innovation Capital (CIC) is a UK-based venture capital firm backing entrepreneurs in life sciences and deep tech, leveraging its position in the Cambridge science and technology ecosystem.
7wire Ventures builds and invests in early-stage digital health companies focused on empowering informed, connected health consumers.
▶17 more co-investors
Vivo CapitalAccess IndustriesCodon CapitalTechstarsInnovation EndeavorsMadrona Venture GroupPolaris PartnersDN CapitalWhat If VenturesSofinnova PartnersConnecticut InnovationsParkwalk AdvisorsOmega Venture PartnersSageview CapitalPICUS CAPITALArtis VenturesQiming Venture Partners
Firms observed investing alongside Digitalis Ventures, from public investor directories. Shared companies are the overlap with Digitalis Ventures's recorded portfolio.
Similar investors
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
5AM Ventures is a life science venture capital firm founded in 2002 that funds and builds next-generation life sciences companies, focusing on biopharmaceuticals, drug delivery technologies, and life science instruments.
LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.